Summary by Futu AI
Jacob D. Cohen, CEO of Mangoceuticals, completed a transaction involving the company's common stock on August 26, 2024. The action, classified as a bona fide gift, consisted of both acquiring and disposing of 800,000 shares at no cost. Following the transaction, Cohen's direct holdings in Mangoceuticals common stock amounted to 9,075,000 shares.